Nexalin closes partial over-allotment exercise, raising $312K at $1.30/share

Nexalin Technology, Inc.

On June 5, 2025, Maxim Group partially exercised its over-allotment option for 240,000 shares.
Shares sold at $1.30 each; aggregate gross proceeds of $312,000 before underwriting discounts.
Closing occurred on June 6, 2025; total shares sold in offering now 4,090,000.
Over-allotment was part of a May 2025 firm commitment public offering initially covering 3,850,000 shares.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.